Challenges coexist with opportunities: development of a macrocyclic peptide PET radioligand for PD-L1

Eur J Nucl Med Mol Imaging. 2024 May;51(6):1574-1577. doi: 10.1007/s00259-024-06680-3.

¹ Department of Nuclear Medicine, Peking University First Hospital, No.8 Xishiku Str, Xicheng District, Beijing, 100034, China.
² Department of Nuclear Medicine, Hospital 108, Hanoi, Vietnam.
³ Department of Nuclear Medicine, Peking University First Hospital, No.8 Xishiku Str, Xicheng District, Beijing, 100034, China. kanglei@bjmu.edu.cn.
⁴ Departments of Radiology and Medical Physics, University of Wisconsin - Madison, K6/562 Clinical Science Center, 600 Highland Ave, Madison, WI, 53705-2275, USA. wcai@uwhealth.org.

No abstract available

Publication types